Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Transient disruption of autocrine TGF-beta signaling leads to enhanced survival and proliferation potential in single primitive human hemopoietic progenitor cells.

In English

Författare

Summary, in English

Hemopoietic stem cells (HSCs) are maintained at relative quiescence by the balance between the positive and negative regulatory factors that stimulate or inhibit their proliferation. Blocking the action of negative regulatory factors may provide a new approach for inducing HSCs into proliferation. A variety of studies have suggested that TGF-beta negatively regulates cell cycle progression of HSCs. In this study, a dominant negatively acting mutant of TGF-beta type II receptor (TbetaRIIDN) was transiently expressed in HSCs by using adenoviral vector-mediated gene delivery, such that the effects of disrupting the autocrine TGF-beta signaling in HSCs can be directly examined at a single cell level. Adenoviral vectors allowing the expression of TbetaRIIDN and green fluorescence protein in the same CD34(+)CD38(-)Lin(-) cells were constructed. Overexpression of TbetaRIIDN specifically disrupted TGF-beta-mediated signaling. Autocrine TGF-beta signaling in CD34(+)CD38(-)Lin(-) cells was studied in single cell assays under serum-free conditions. Transient blockage of autocrine TGF-beta signaling in CD34(+)CD38(-)Lin(-) cells enhanced their survival. Furthermore, the overall proliferation potential and proliferation kinetics in these cells were significantly enhanced compared with the CD34(+)CD38(-)Lin(-) cells expressing green fluorescence protein alone. Therefore, we have successfully blocked the autocrine TGF-beta-negative regulatory loop of primitive hemopoietic progenitor cells.

Publiceringsår

2002

Språk

Engelska

Sidor

755-762

Publikation/Tidskrift/Serie

Journal of Immunology

Volym

168

Issue

2

Dokumenttyp

Artikel i tidskrift

Förlag

American Association of Immunologists

Ämne

  • Immunology in the medical area

Nyckelord

  • Cell Lineage : genetics
  • Cell Division : genetics
  • Cell Survival : genetics
  • Cells Cultured
  • Culture Media Serum-Free
  • Genetic Vectors : biosynthesis
  • Hela Cells
  • Hematopoietic Stem Cells : cytology : immunology : metabolism
  • Human
  • Immunophenotyping
  • NAD+ Nucleosidase : biosynthesis
  • K562 Cells
  • Signal Transduction : genetics : physiology
  • Support Non-U.S. Gov't
  • Transforming Growth Factor beta : antagonists & inhibitors : genetics : pharmacology : physiology
  • Transduction Genetic
  • Cell Cycle : genetics
  • Cattle
  • Autocrine Communication : genetics
  • Antigens Differentiation : biosynthesis
  • Antigens CD34 : biosynthesis
  • Animal
  • Adenoviridae : genetics

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1550-6606